UCLA - University of California, Los Angeles — Los Angeles, California

UCLA - University of California, Los Angeles is a clinical research site located in Los Angeles, California, United States 90095.

Crixeo Health Trust Score: 46/100 (POOR). This profile has not yet been claimed by the site owner.

UCLA - University of California, Los Angeles has participated in 1 clinical trials.

Therapeutic areas: Carcinoma, Transitional Cell Carcinoma, Transitional Cell Cancer of the Renal Pelvis and Ureter.

Sponsors: UroGen Pharma Ltd..

Sponsor Feasibility Report

Trust Score: 46/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA - University of California, Los Angeles?

UCLA - University of California, Los Angeles has a Crixeo Trust Score of 46/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA - University of California, Los Angeles conducted?

UCLA - University of California, Los Angeles has 1 clinical trials on record. Their work covers Carcinoma, Transitional Cell Carcinoma, Transitional Cell Cancer of the Renal Pelvis and Ureter.

Is UCLA - University of California, Los Angeles accredited by Crixeo Health?

UCLA - University of California, Los Angeles has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCLA - University of California, Los Angeles?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.